Global Inflammatory Bowel Disease (IBD) Drugs Market Research Report 2023
This report aims to provide a comprehensive presentation of the global market for Inflammatory Bowel Disease (IBD) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inflammatory Bowel Disease (IBD) Drugs.
The Inflammatory Bowel Disease (IBD) Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Inflammatory Bowel Disease (IBD) Drugs market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inflammatory Bowel Disease (IBD) Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Inflammatory Bowel Disease (IBD) Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Inflammatory Bowel Disease (IBD) Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Inflammatory Bowel Disease (IBD) Drugs market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inflammatory Bowel Disease (IBD) Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
- Abbott Laboratories
- Biocon Ltd
- Johnson and Johnson
- Novartis AG
- Pfizer
- Quest Medical
- Sanofi
- Takeda Pharmaceutical
- UCB Pharma
- AbbVie
- Zhejiang Hisun Pharmaceutical Co.,Ltd.
- North China Pharmaceutical Co., Ltd.
- Zhejiang Zhebei Pharmaceutical Co., Ltd.
- Huadong Medicine Co., Ltd.
- Shenzhen Salubris Pharmaceuticals Co.,Ltd.
- Heilongjiang Tianhong Pharmaceutical Co., Ltd.
- Aminosalicylate
- Corticosteroid Hormone
- Immunosuppressants
- Biological Agents
- Ulceratory Colitis
- Crohn's Disease
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Inflammatory Bowel Disease (IBD) Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Inflammatory Bowel Disease (IBD) Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Aminosalicylate
1.2.3 Corticosteroid Hormone
1.2.4 Immunosuppressants
1.2.5 Biological Agents
1.3 Market by Application
1.3.1 Global Inflammatory Bowel Disease (IBD) Drugs Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Ulceratory Colitis
1.3.3 Crohn's Disease
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Inflammatory Bowel Disease (IBD) Drugs Market Perspective (2018-2029)
2.2 Inflammatory Bowel Disease (IBD) Drugs Growth Trends by Region
2.2.1 Global Inflammatory Bowel Disease (IBD) Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Inflammatory Bowel Disease (IBD) Drugs Historic Market Size by Region (2018-2023)
2.2.3 Inflammatory Bowel Disease (IBD) Drugs Forecasted Market Size by Region (2024-2029)
2.3 Inflammatory Bowel Disease (IBD) Drugs Market Dynamics
2.3.1 Inflammatory Bowel Disease (IBD) Drugs Industry Trends
2.3.2 Inflammatory Bowel Disease (IBD) Drugs Market Drivers
2.3.3 Inflammatory Bowel Disease (IBD) Drugs Market Challenges
2.3.4 Inflammatory Bowel Disease (IBD) Drugs Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Inflammatory Bowel Disease (IBD) Drugs Players by Revenue
3.1.1 Global Top Inflammatory Bowel Disease (IBD) Drugs Players by Revenue (2018-2023)
3.1.2 Global Inflammatory Bowel Disease (IBD) Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Inflammatory Bowel Disease (IBD) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Inflammatory Bowel Disease (IBD) Drugs Revenue
3.4 Global Inflammatory Bowel Disease (IBD) Drugs Market Concentration Ratio
3.4.1 Global Inflammatory Bowel Disease (IBD) Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Inflammatory Bowel Disease (IBD) Drugs Revenue in 2022
3.5 Inflammatory Bowel Disease (IBD) Drugs Key Players Head office and Area Served
3.6 Key Players Inflammatory Bowel Disease (IBD) Drugs Product Solution and Service
3.7 Date of Enter into Inflammatory Bowel Disease (IBD) Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 INFLAMMATORY BOWEL DISEASE (IBD) DRUGS BREAKDOWN DATA BY TYPE
4.1 Global Inflammatory Bowel Disease (IBD) Drugs Historic Market Size by Type (2018-2023)
4.2 Global Inflammatory Bowel Disease (IBD) Drugs Forecasted Market Size by Type (2024-2029)
5 INFLAMMATORY BOWEL DISEASE (IBD) DRUGS BREAKDOWN DATA BY APPLICATION
5.1 Global Inflammatory Bowel Disease (IBD) Drugs Historic Market Size by Application (2018-2023)
5.2 Global Inflammatory Bowel Disease (IBD) Drugs Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Inflammatory Bowel Disease (IBD) Drugs Market Size (2018-2029)
6.2 North America Inflammatory Bowel Disease (IBD) Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2018-2023)
6.4 North America Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Inflammatory Bowel Disease (IBD) Drugs Market Size (2018-2029)
7.2 Europe Inflammatory Bowel Disease (IBD) Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2018-2023)
7.4 Europe Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Inflammatory Bowel Disease (IBD) Drugs Market Size (2018-2029)
8.2 Asia-Pacific Inflammatory Bowel Disease (IBD) Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Inflammatory Bowel Disease (IBD) Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Inflammatory Bowel Disease (IBD) Drugs Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Inflammatory Bowel Disease (IBD) Drugs Market Size (2018-2029)
9.2 Latin America Inflammatory Bowel Disease (IBD) Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2018-2023)
9.4 Latin America Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Inflammatory Bowel Disease (IBD) Drugs Market Size (2018-2029)
10.2 Middle East & Africa Inflammatory Bowel Disease (IBD) Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Inflammatory Bowel Disease (IBD) Drugs Introduction
11.1.4 Abbott Laboratories Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 Biocon Ltd
11.2.1 Biocon Ltd Company Detail
11.2.2 Biocon Ltd Business Overview
11.2.3 Biocon Ltd Inflammatory Bowel Disease (IBD) Drugs Introduction
11.2.4 Biocon Ltd Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
11.2.5 Biocon Ltd Recent Development
11.3 Johnson and Johnson
11.3.1 Johnson and Johnson Company Detail
11.3.2 Johnson and Johnson Business Overview
11.3.3 Johnson and Johnson Inflammatory Bowel Disease (IBD) Drugs Introduction
11.3.4 Johnson and Johnson Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
11.3.5 Johnson and Johnson Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Detail
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Inflammatory Bowel Disease (IBD) Drugs Introduction
11.4.4 Novartis AG Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
11.4.5 Novartis AG Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Inflammatory Bowel Disease (IBD) Drugs Introduction
11.5.4 Pfizer Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
11.5.5 Pfizer Recent Development
11.6 Quest Medical
11.6.1 Quest Medical Company Detail
11.6.2 Quest Medical Business Overview
11.6.3 Quest Medical Inflammatory Bowel Disease (IBD) Drugs Introduction
11.6.4 Quest Medical Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
11.6.5 Quest Medical Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Detail
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Inflammatory Bowel Disease (IBD) Drugs Introduction
11.7.4 Sanofi Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
11.7.5 Sanofi Recent Development
11.8 Takeda Pharmaceutical
11.8.1 Takeda Pharmaceutical Company Detail
11.8.2 Takeda Pharmaceutical Business Overview
11.8.3 Takeda Pharmaceutical Inflammatory Bowel Disease (IBD) Drugs Introduction
11.8.4 Takeda Pharmaceutical Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
11.8.5 Takeda Pharmaceutical Recent Development
11.9 UCB Pharma
11.9.1 UCB Pharma Company Detail
11.9.2 UCB Pharma Business Overview
11.9.3 UCB Pharma Inflammatory Bowel Disease (IBD) Drugs Introduction
11.9.4 UCB Pharma Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
11.9.5 UCB Pharma Recent Development
11.10 AbbVie
11.10.1 AbbVie Company Detail
11.10.2 AbbVie Business Overview
11.10.3 AbbVie Inflammatory Bowel Disease (IBD) Drugs Introduction
11.10.4 AbbVie Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
11.10.5 AbbVie Recent Development
11.11 Zhejiang Hisun Pharmaceutical Co.,Ltd.
11.11.1 Zhejiang Hisun Pharmaceutical Co.,Ltd. Company Detail
11.11.2 Zhejiang Hisun Pharmaceutical Co.,Ltd. Business Overview
11.11.3 Zhejiang Hisun Pharmaceutical Co.,Ltd. Inflammatory Bowel Disease (IBD) Drugs Introduction
11.11.4 Zhejiang Hisun Pharmaceutical Co.,Ltd. Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
11.11.5 Zhejiang Hisun Pharmaceutical Co.,Ltd. Recent Development
11.12 North China Pharmaceutical Co., Ltd.
11.12.1 North China Pharmaceutical Co., Ltd. Company Detail
11.12.2 North China Pharmaceutical Co., Ltd. Business Overview
11.12.3 North China Pharmaceutical Co., Ltd. Inflammatory Bowel Disease (IBD) Drugs Introduction
11.12.4 North China Pharmaceutical Co., Ltd. Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
11.12.5 North China Pharmaceutical Co., Ltd. Recent Development
11.13 Zhejiang Zhebei Pharmaceutical Co., Ltd.
11.13.1 Zhejiang Zhebei Pharmaceutical Co., Ltd. Company Detail
11.13.2 Zhejiang Zhebei Pharmaceutical Co., Ltd. Business Overview
11.13.3 Zhejiang Zhebei Pharmaceutical Co., Ltd. Inflammatory Bowel Disease (IBD) Drugs Introduction
11.13.4 Zhejiang Zhebei Pharmaceutical Co., Ltd. Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
11.13.5 Zhejiang Zhebei Pharmaceutical Co., Ltd. Recent Development
11.14 Huadong Medicine Co., Ltd.
11.14.1 Huadong Medicine Co., Ltd. Company Detail
11.14.2 Huadong Medicine Co., Ltd. Business Overview
11.14.3 Huadong Medicine Co., Ltd. Inflammatory Bowel Disease (IBD) Drugs Introduction
11.14.4 Huadong Medicine Co., Ltd. Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
11.14.5 Huadong Medicine Co., Ltd. Recent Development
11.15 Shenzhen Salubris Pharmaceuticals Co.,Ltd.
11.15.1 Shenzhen Salubris Pharmaceuticals Co.,Ltd. Company Detail
11.15.2 Shenzhen Salubris Pharmaceuticals Co.,Ltd. Business Overview
11.15.3 Shenzhen Salubris Pharmaceuticals Co.,Ltd. Inflammatory Bowel Disease (IBD) Drugs Introduction
11.15.4 Shenzhen Salubris Pharmaceuticals Co.,Ltd. Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
11.15.5 Shenzhen Salubris Pharmaceuticals Co.,Ltd. Recent Development
11.16 Heilongjiang Tianhong Pharmaceutical Co., Ltd.
11.16.1 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Company Detail
11.16.2 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Business Overview
11.16.3 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Inflammatory Bowel Disease (IBD) Drugs Introduction
11.16.4 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
11.16.5 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Inflammatory Bowel Disease (IBD) Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Aminosalicylate
1.2.3 Corticosteroid Hormone
1.2.4 Immunosuppressants
1.2.5 Biological Agents
1.3 Market by Application
1.3.1 Global Inflammatory Bowel Disease (IBD) Drugs Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Ulceratory Colitis
1.3.3 Crohn's Disease
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Inflammatory Bowel Disease (IBD) Drugs Market Perspective (2018-2029)
2.2 Inflammatory Bowel Disease (IBD) Drugs Growth Trends by Region
2.2.1 Global Inflammatory Bowel Disease (IBD) Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Inflammatory Bowel Disease (IBD) Drugs Historic Market Size by Region (2018-2023)
2.2.3 Inflammatory Bowel Disease (IBD) Drugs Forecasted Market Size by Region (2024-2029)
2.3 Inflammatory Bowel Disease (IBD) Drugs Market Dynamics
2.3.1 Inflammatory Bowel Disease (IBD) Drugs Industry Trends
2.3.2 Inflammatory Bowel Disease (IBD) Drugs Market Drivers
2.3.3 Inflammatory Bowel Disease (IBD) Drugs Market Challenges
2.3.4 Inflammatory Bowel Disease (IBD) Drugs Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Inflammatory Bowel Disease (IBD) Drugs Players by Revenue
3.1.1 Global Top Inflammatory Bowel Disease (IBD) Drugs Players by Revenue (2018-2023)
3.1.2 Global Inflammatory Bowel Disease (IBD) Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Inflammatory Bowel Disease (IBD) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Inflammatory Bowel Disease (IBD) Drugs Revenue
3.4 Global Inflammatory Bowel Disease (IBD) Drugs Market Concentration Ratio
3.4.1 Global Inflammatory Bowel Disease (IBD) Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Inflammatory Bowel Disease (IBD) Drugs Revenue in 2022
3.5 Inflammatory Bowel Disease (IBD) Drugs Key Players Head office and Area Served
3.6 Key Players Inflammatory Bowel Disease (IBD) Drugs Product Solution and Service
3.7 Date of Enter into Inflammatory Bowel Disease (IBD) Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 INFLAMMATORY BOWEL DISEASE (IBD) DRUGS BREAKDOWN DATA BY TYPE
4.1 Global Inflammatory Bowel Disease (IBD) Drugs Historic Market Size by Type (2018-2023)
4.2 Global Inflammatory Bowel Disease (IBD) Drugs Forecasted Market Size by Type (2024-2029)
5 INFLAMMATORY BOWEL DISEASE (IBD) DRUGS BREAKDOWN DATA BY APPLICATION
5.1 Global Inflammatory Bowel Disease (IBD) Drugs Historic Market Size by Application (2018-2023)
5.2 Global Inflammatory Bowel Disease (IBD) Drugs Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Inflammatory Bowel Disease (IBD) Drugs Market Size (2018-2029)
6.2 North America Inflammatory Bowel Disease (IBD) Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2018-2023)
6.4 North America Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Inflammatory Bowel Disease (IBD) Drugs Market Size (2018-2029)
7.2 Europe Inflammatory Bowel Disease (IBD) Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2018-2023)
7.4 Europe Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Inflammatory Bowel Disease (IBD) Drugs Market Size (2018-2029)
8.2 Asia-Pacific Inflammatory Bowel Disease (IBD) Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Inflammatory Bowel Disease (IBD) Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Inflammatory Bowel Disease (IBD) Drugs Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Inflammatory Bowel Disease (IBD) Drugs Market Size (2018-2029)
9.2 Latin America Inflammatory Bowel Disease (IBD) Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2018-2023)
9.4 Latin America Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Inflammatory Bowel Disease (IBD) Drugs Market Size (2018-2029)
10.2 Middle East & Africa Inflammatory Bowel Disease (IBD) Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Inflammatory Bowel Disease (IBD) Drugs Introduction
11.1.4 Abbott Laboratories Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 Biocon Ltd
11.2.1 Biocon Ltd Company Detail
11.2.2 Biocon Ltd Business Overview
11.2.3 Biocon Ltd Inflammatory Bowel Disease (IBD) Drugs Introduction
11.2.4 Biocon Ltd Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
11.2.5 Biocon Ltd Recent Development
11.3 Johnson and Johnson
11.3.1 Johnson and Johnson Company Detail
11.3.2 Johnson and Johnson Business Overview
11.3.3 Johnson and Johnson Inflammatory Bowel Disease (IBD) Drugs Introduction
11.3.4 Johnson and Johnson Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
11.3.5 Johnson and Johnson Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Detail
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Inflammatory Bowel Disease (IBD) Drugs Introduction
11.4.4 Novartis AG Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
11.4.5 Novartis AG Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Inflammatory Bowel Disease (IBD) Drugs Introduction
11.5.4 Pfizer Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
11.5.5 Pfizer Recent Development
11.6 Quest Medical
11.6.1 Quest Medical Company Detail
11.6.2 Quest Medical Business Overview
11.6.3 Quest Medical Inflammatory Bowel Disease (IBD) Drugs Introduction
11.6.4 Quest Medical Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
11.6.5 Quest Medical Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Detail
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Inflammatory Bowel Disease (IBD) Drugs Introduction
11.7.4 Sanofi Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
11.7.5 Sanofi Recent Development
11.8 Takeda Pharmaceutical
11.8.1 Takeda Pharmaceutical Company Detail
11.8.2 Takeda Pharmaceutical Business Overview
11.8.3 Takeda Pharmaceutical Inflammatory Bowel Disease (IBD) Drugs Introduction
11.8.4 Takeda Pharmaceutical Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
11.8.5 Takeda Pharmaceutical Recent Development
11.9 UCB Pharma
11.9.1 UCB Pharma Company Detail
11.9.2 UCB Pharma Business Overview
11.9.3 UCB Pharma Inflammatory Bowel Disease (IBD) Drugs Introduction
11.9.4 UCB Pharma Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
11.9.5 UCB Pharma Recent Development
11.10 AbbVie
11.10.1 AbbVie Company Detail
11.10.2 AbbVie Business Overview
11.10.3 AbbVie Inflammatory Bowel Disease (IBD) Drugs Introduction
11.10.4 AbbVie Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
11.10.5 AbbVie Recent Development
11.11 Zhejiang Hisun Pharmaceutical Co.,Ltd.
11.11.1 Zhejiang Hisun Pharmaceutical Co.,Ltd. Company Detail
11.11.2 Zhejiang Hisun Pharmaceutical Co.,Ltd. Business Overview
11.11.3 Zhejiang Hisun Pharmaceutical Co.,Ltd. Inflammatory Bowel Disease (IBD) Drugs Introduction
11.11.4 Zhejiang Hisun Pharmaceutical Co.,Ltd. Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
11.11.5 Zhejiang Hisun Pharmaceutical Co.,Ltd. Recent Development
11.12 North China Pharmaceutical Co., Ltd.
11.12.1 North China Pharmaceutical Co., Ltd. Company Detail
11.12.2 North China Pharmaceutical Co., Ltd. Business Overview
11.12.3 North China Pharmaceutical Co., Ltd. Inflammatory Bowel Disease (IBD) Drugs Introduction
11.12.4 North China Pharmaceutical Co., Ltd. Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
11.12.5 North China Pharmaceutical Co., Ltd. Recent Development
11.13 Zhejiang Zhebei Pharmaceutical Co., Ltd.
11.13.1 Zhejiang Zhebei Pharmaceutical Co., Ltd. Company Detail
11.13.2 Zhejiang Zhebei Pharmaceutical Co., Ltd. Business Overview
11.13.3 Zhejiang Zhebei Pharmaceutical Co., Ltd. Inflammatory Bowel Disease (IBD) Drugs Introduction
11.13.4 Zhejiang Zhebei Pharmaceutical Co., Ltd. Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
11.13.5 Zhejiang Zhebei Pharmaceutical Co., Ltd. Recent Development
11.14 Huadong Medicine Co., Ltd.
11.14.1 Huadong Medicine Co., Ltd. Company Detail
11.14.2 Huadong Medicine Co., Ltd. Business Overview
11.14.3 Huadong Medicine Co., Ltd. Inflammatory Bowel Disease (IBD) Drugs Introduction
11.14.4 Huadong Medicine Co., Ltd. Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
11.14.5 Huadong Medicine Co., Ltd. Recent Development
11.15 Shenzhen Salubris Pharmaceuticals Co.,Ltd.
11.15.1 Shenzhen Salubris Pharmaceuticals Co.,Ltd. Company Detail
11.15.2 Shenzhen Salubris Pharmaceuticals Co.,Ltd. Business Overview
11.15.3 Shenzhen Salubris Pharmaceuticals Co.,Ltd. Inflammatory Bowel Disease (IBD) Drugs Introduction
11.15.4 Shenzhen Salubris Pharmaceuticals Co.,Ltd. Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
11.15.5 Shenzhen Salubris Pharmaceuticals Co.,Ltd. Recent Development
11.16 Heilongjiang Tianhong Pharmaceutical Co., Ltd.
11.16.1 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Company Detail
11.16.2 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Business Overview
11.16.3 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Inflammatory Bowel Disease (IBD) Drugs Introduction
11.16.4 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
11.16.5 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Inflammatory Bowel Disease (IBD) Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Aminosalicylate
Table 3. Key Players of Corticosteroid Hormone
Table 4. Key Players of Immunosuppressants
Table 5. Key Players of Biological Agents
Table 6. Global Inflammatory Bowel Disease (IBD) Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Inflammatory Bowel Disease (IBD) Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Inflammatory Bowel Disease (IBD) Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Inflammatory Bowel Disease (IBD) Drugs Market Share by Region (2018-2023)
Table 10. Global Inflammatory Bowel Disease (IBD) Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Inflammatory Bowel Disease (IBD) Drugs Market Share by Region (2024-2029)
Table 12. Inflammatory Bowel Disease (IBD) Drugs Market Trends
Table 13. Inflammatory Bowel Disease (IBD) Drugs Market Drivers
Table 14. Inflammatory Bowel Disease (IBD) Drugs Market Challenges
Table 15. Inflammatory Bowel Disease (IBD) Drugs Market Restraints
Table 16. Global Inflammatory Bowel Disease (IBD) Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Inflammatory Bowel Disease (IBD) Drugs Market Share by Players (2018-2023)
Table 18. Global Top Inflammatory Bowel Disease (IBD) Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inflammatory Bowel Disease (IBD) Drugs as of 2022)
Table 19. Ranking of Global Top Inflammatory Bowel Disease (IBD) Drugs Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Inflammatory Bowel Disease (IBD) Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Inflammatory Bowel Disease (IBD) Drugs Product Solution and Service
Table 23. Date of Enter into Inflammatory Bowel Disease (IBD) Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Inflammatory Bowel Disease (IBD) Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Inflammatory Bowel Disease (IBD) Drugs Revenue Market Share by Type (2018-2023)
Table 27. Global Inflammatory Bowel Disease (IBD) Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Inflammatory Bowel Disease (IBD) Drugs Revenue Market Share by Type (2024-2029)
Table 29. Global Inflammatory Bowel Disease (IBD) Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Inflammatory Bowel Disease (IBD) Drugs Revenue Market Share by Application (2018-2023)
Table 31. Global Inflammatory Bowel Disease (IBD) Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Inflammatory Bowel Disease (IBD) Drugs Revenue Market Share by Application (2024-2029)
Table 33. North America Inflammatory Bowel Disease (IBD) Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Inflammatory Bowel Disease (IBD) Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Inflammatory Bowel Disease (IBD) Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Inflammatory Bowel Disease (IBD) Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Inflammatory Bowel Disease (IBD) Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Inflammatory Bowel Disease (IBD) Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Inflammatory Bowel Disease (IBD) Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 48. Abbott Laboratories Company Detail
Table 49. Abbott Laboratories Business Overview
Table 50. Abbott Laboratories Inflammatory Bowel Disease (IBD) Drugs Product
Table 51. Abbott Laboratories Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023) & (US$ Million)
Table 52. Abbott Laboratories Recent Development
Table 53. Biocon Ltd Company Detail
Table 54. Biocon Ltd Business Overview
Table 55. Biocon Ltd Inflammatory Bowel Disease (IBD) Drugs Product
Table 56. Biocon Ltd Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023) & (US$ Million)
Table 57. Biocon Ltd Recent Development
Table 58. Johnson and Johnson Company Detail
Table 59. Johnson and Johnson Business Overview
Table 60. Johnson and Johnson Inflammatory Bowel Disease (IBD) Drugs Product
Table 61. Johnson and Johnson Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023) & (US$ Million)
Table 62. Johnson and Johnson Recent Development
Table 63. Novartis AG Company Detail
Table 64. Novartis AG Business Overview
Table 65. Novartis AG Inflammatory Bowel Disease (IBD) Drugs Product
Table 66. Novartis AG Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023) & (US$ Million)
Table 67. Novartis AG Recent Development
Table 68. Pfizer Company Detail
Table 69. Pfizer Business Overview
Table 70. Pfizer Inflammatory Bowel Disease (IBD) Drugs Product
Table 71. Pfizer Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023) & (US$ Million)
Table 72. Pfizer Recent Development
Table 73. Quest Medical Company Detail
Table 74. Quest Medical Business Overview
Table 75. Quest Medical Inflammatory Bowel Disease (IBD) Drugs Product
Table 76. Quest Medical Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023) & (US$ Million)
Table 77. Quest Medical Recent Development
Table 78. Sanofi Company Detail
Table 79. Sanofi Business Overview
Table 80. Sanofi Inflammatory Bowel Disease (IBD) Drugs Product
Table 81. Sanofi Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023) & (US$ Million)
Table 82. Sanofi Recent Development
Table 83. Takeda Pharmaceutical Company Detail
Table 84. Takeda Pharmaceutical Business Overview
Table 85. Takeda Pharmaceutical Inflammatory Bowel Disease (IBD) Drugs Product
Table 86. Takeda Pharmaceutical Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023) & (US$ Million)
Table 87. Takeda Pharmaceutical Recent Development
Table 88. UCB Pharma Company Detail
Table 89. UCB Pharma Business Overview
Table 90. UCB Pharma Inflammatory Bowel Disease (IBD) Drugs Product
Table 91. UCB Pharma Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023) & (US$ Million)
Table 92. UCB Pharma Recent Development
Table 93. AbbVie Company Detail
Table 94. AbbVie Business Overview
Table 95. AbbVie Inflammatory Bowel Disease (IBD) Drugs Product
Table 96. AbbVie Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023) & (US$ Million)
Table 97. AbbVie Recent Development
Table 98. Zhejiang Hisun Pharmaceutical Co.,Ltd. Company Detail
Table 99. Zhejiang Hisun Pharmaceutical Co.,Ltd. Business Overview
Table 100. Zhejiang Hisun Pharmaceutical Co.,Ltd. Inflammatory Bowel Disease (IBD) Drugs Product
Table 101. Zhejiang Hisun Pharmaceutical Co.,Ltd. Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023) & (US$ Million)
Table 102. Zhejiang Hisun Pharmaceutical Co.,Ltd. Recent Development
Table 103. North China Pharmaceutical Co., Ltd. Company Detail
Table 104. North China Pharmaceutical Co., Ltd. Business Overview
Table 105. North China Pharmaceutical Co., Ltd. Inflammatory Bowel Disease (IBD) Drugs Product
Table 106. North China Pharmaceutical Co., Ltd. Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023) & (US$ Million)
Table 107. North China Pharmaceutical Co., Ltd. Recent Development
Table 108. Zhejiang Zhebei Pharmaceutical Co., Ltd. Company Detail
Table 109. Zhejiang Zhebei Pharmaceutical Co., Ltd. Business Overview
Table 110. Zhejiang Zhebei Pharmaceutical Co., Ltd. Inflammatory Bowel Disease (IBD) Drugs Product
Table 111. Zhejiang Zhebei Pharmaceutical Co., Ltd. Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023) & (US$ Million)
Table 112. Zhejiang Zhebei Pharmaceutical Co., Ltd. Recent Development
Table 113. Huadong Medicine Co., Ltd. Company Detail
Table 114. Huadong Medicine Co., Ltd. Business Overview
Table 115. Huadong Medicine Co., Ltd. Inflammatory Bowel Disease (IBD) Drugs Product
Table 116. Huadong Medicine Co., Ltd. Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023) & (US$ Million)
Table 117. Huadong Medicine Co., Ltd. Recent Development
Table 118. Shenzhen Salubris Pharmaceuticals Co.,Ltd. Company Detail
Table 119. Shenzhen Salubris Pharmaceuticals Co.,Ltd. Business Overview
Table 120. Shenzhen Salubris Pharmaceuticals Co.,Ltd. Inflammatory Bowel Disease (IBD) Drugs Product
Table 121. Shenzhen Salubris Pharmaceuticals Co.,Ltd. Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023) & (US$ Million)
Table 122. Shenzhen Salubris Pharmaceuticals Co.,Ltd. Recent Development
Table 123. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Company Detail
Table 124. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Business Overview
Table 125. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Inflammatory Bowel Disease (IBD) Drugs Product
Table 126. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023) & (US$ Million)
Table 127. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 1. Global Inflammatory Bowel Disease (IBD) Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Aminosalicylate
Table 3. Key Players of Corticosteroid Hormone
Table 4. Key Players of Immunosuppressants
Table 5. Key Players of Biological Agents
Table 6. Global Inflammatory Bowel Disease (IBD) Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Inflammatory Bowel Disease (IBD) Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Inflammatory Bowel Disease (IBD) Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Inflammatory Bowel Disease (IBD) Drugs Market Share by Region (2018-2023)
Table 10. Global Inflammatory Bowel Disease (IBD) Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Inflammatory Bowel Disease (IBD) Drugs Market Share by Region (2024-2029)
Table 12. Inflammatory Bowel Disease (IBD) Drugs Market Trends
Table 13. Inflammatory Bowel Disease (IBD) Drugs Market Drivers
Table 14. Inflammatory Bowel Disease (IBD) Drugs Market Challenges
Table 15. Inflammatory Bowel Disease (IBD) Drugs Market Restraints
Table 16. Global Inflammatory Bowel Disease (IBD) Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Inflammatory Bowel Disease (IBD) Drugs Market Share by Players (2018-2023)
Table 18. Global Top Inflammatory Bowel Disease (IBD) Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inflammatory Bowel Disease (IBD) Drugs as of 2022)
Table 19. Ranking of Global Top Inflammatory Bowel Disease (IBD) Drugs Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Inflammatory Bowel Disease (IBD) Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Inflammatory Bowel Disease (IBD) Drugs Product Solution and Service
Table 23. Date of Enter into Inflammatory Bowel Disease (IBD) Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Inflammatory Bowel Disease (IBD) Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Inflammatory Bowel Disease (IBD) Drugs Revenue Market Share by Type (2018-2023)
Table 27. Global Inflammatory Bowel Disease (IBD) Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Inflammatory Bowel Disease (IBD) Drugs Revenue Market Share by Type (2024-2029)
Table 29. Global Inflammatory Bowel Disease (IBD) Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Inflammatory Bowel Disease (IBD) Drugs Revenue Market Share by Application (2018-2023)
Table 31. Global Inflammatory Bowel Disease (IBD) Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Inflammatory Bowel Disease (IBD) Drugs Revenue Market Share by Application (2024-2029)
Table 33. North America Inflammatory Bowel Disease (IBD) Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Inflammatory Bowel Disease (IBD) Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Inflammatory Bowel Disease (IBD) Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Inflammatory Bowel Disease (IBD) Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Inflammatory Bowel Disease (IBD) Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Inflammatory Bowel Disease (IBD) Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Inflammatory Bowel Disease (IBD) Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Inflammatory Bowel Disease (IBD) Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 48. Abbott Laboratories Company Detail
Table 49. Abbott Laboratories Business Overview
Table 50. Abbott Laboratories Inflammatory Bowel Disease (IBD) Drugs Product
Table 51. Abbott Laboratories Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023) & (US$ Million)
Table 52. Abbott Laboratories Recent Development
Table 53. Biocon Ltd Company Detail
Table 54. Biocon Ltd Business Overview
Table 55. Biocon Ltd Inflammatory Bowel Disease (IBD) Drugs Product
Table 56. Biocon Ltd Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023) & (US$ Million)
Table 57. Biocon Ltd Recent Development
Table 58. Johnson and Johnson Company Detail
Table 59. Johnson and Johnson Business Overview
Table 60. Johnson and Johnson Inflammatory Bowel Disease (IBD) Drugs Product
Table 61. Johnson and Johnson Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023) & (US$ Million)
Table 62. Johnson and Johnson Recent Development
Table 63. Novartis AG Company Detail
Table 64. Novartis AG Business Overview
Table 65. Novartis AG Inflammatory Bowel Disease (IBD) Drugs Product
Table 66. Novartis AG Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023) & (US$ Million)
Table 67. Novartis AG Recent Development
Table 68. Pfizer Company Detail
Table 69. Pfizer Business Overview
Table 70. Pfizer Inflammatory Bowel Disease (IBD) Drugs Product
Table 71. Pfizer Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023) & (US$ Million)
Table 72. Pfizer Recent Development
Table 73. Quest Medical Company Detail
Table 74. Quest Medical Business Overview
Table 75. Quest Medical Inflammatory Bowel Disease (IBD) Drugs Product
Table 76. Quest Medical Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023) & (US$ Million)
Table 77. Quest Medical Recent Development
Table 78. Sanofi Company Detail
Table 79. Sanofi Business Overview
Table 80. Sanofi Inflammatory Bowel Disease (IBD) Drugs Product
Table 81. Sanofi Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023) & (US$ Million)
Table 82. Sanofi Recent Development
Table 83. Takeda Pharmaceutical Company Detail
Table 84. Takeda Pharmaceutical Business Overview
Table 85. Takeda Pharmaceutical Inflammatory Bowel Disease (IBD) Drugs Product
Table 86. Takeda Pharmaceutical Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023) & (US$ Million)
Table 87. Takeda Pharmaceutical Recent Development
Table 88. UCB Pharma Company Detail
Table 89. UCB Pharma Business Overview
Table 90. UCB Pharma Inflammatory Bowel Disease (IBD) Drugs Product
Table 91. UCB Pharma Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023) & (US$ Million)
Table 92. UCB Pharma Recent Development
Table 93. AbbVie Company Detail
Table 94. AbbVie Business Overview
Table 95. AbbVie Inflammatory Bowel Disease (IBD) Drugs Product
Table 96. AbbVie Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023) & (US$ Million)
Table 97. AbbVie Recent Development
Table 98. Zhejiang Hisun Pharmaceutical Co.,Ltd. Company Detail
Table 99. Zhejiang Hisun Pharmaceutical Co.,Ltd. Business Overview
Table 100. Zhejiang Hisun Pharmaceutical Co.,Ltd. Inflammatory Bowel Disease (IBD) Drugs Product
Table 101. Zhejiang Hisun Pharmaceutical Co.,Ltd. Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023) & (US$ Million)
Table 102. Zhejiang Hisun Pharmaceutical Co.,Ltd. Recent Development
Table 103. North China Pharmaceutical Co., Ltd. Company Detail
Table 104. North China Pharmaceutical Co., Ltd. Business Overview
Table 105. North China Pharmaceutical Co., Ltd. Inflammatory Bowel Disease (IBD) Drugs Product
Table 106. North China Pharmaceutical Co., Ltd. Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023) & (US$ Million)
Table 107. North China Pharmaceutical Co., Ltd. Recent Development
Table 108. Zhejiang Zhebei Pharmaceutical Co., Ltd. Company Detail
Table 109. Zhejiang Zhebei Pharmaceutical Co., Ltd. Business Overview
Table 110. Zhejiang Zhebei Pharmaceutical Co., Ltd. Inflammatory Bowel Disease (IBD) Drugs Product
Table 111. Zhejiang Zhebei Pharmaceutical Co., Ltd. Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023) & (US$ Million)
Table 112. Zhejiang Zhebei Pharmaceutical Co., Ltd. Recent Development
Table 113. Huadong Medicine Co., Ltd. Company Detail
Table 114. Huadong Medicine Co., Ltd. Business Overview
Table 115. Huadong Medicine Co., Ltd. Inflammatory Bowel Disease (IBD) Drugs Product
Table 116. Huadong Medicine Co., Ltd. Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023) & (US$ Million)
Table 117. Huadong Medicine Co., Ltd. Recent Development
Table 118. Shenzhen Salubris Pharmaceuticals Co.,Ltd. Company Detail
Table 119. Shenzhen Salubris Pharmaceuticals Co.,Ltd. Business Overview
Table 120. Shenzhen Salubris Pharmaceuticals Co.,Ltd. Inflammatory Bowel Disease (IBD) Drugs Product
Table 121. Shenzhen Salubris Pharmaceuticals Co.,Ltd. Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023) & (US$ Million)
Table 122. Shenzhen Salubris Pharmaceuticals Co.,Ltd. Recent Development
Table 123. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Company Detail
Table 124. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Business Overview
Table 125. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Inflammatory Bowel Disease (IBD) Drugs Product
Table 126. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Revenue in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023) & (US$ Million)
Table 127. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Inflammatory Bowel Disease (IBD) Drugs Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Inflammatory Bowel Disease (IBD) Drugs Market Share by Type: 2022 VS 2029
Figure 3. Aminosalicylate Features
Figure 4. Corticosteroid Hormone Features
Figure 5. Immunosuppressants Features
Figure 6. Biological Agents Features
Figure 7. Global Inflammatory Bowel Disease (IBD) Drugs Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Inflammatory Bowel Disease (IBD) Drugs Market Share by Application: 2022 VS 2029
Figure 9. Ulceratory Colitis Case Studies
Figure 10. Crohn's Disease Case Studies
Figure 11. Inflammatory Bowel Disease (IBD) Drugs Report Years Considered
Figure 12. Global Inflammatory Bowel Disease (IBD) Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Inflammatory Bowel Disease (IBD) Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Inflammatory Bowel Disease (IBD) Drugs Market Share by Region: 2022 VS 2029
Figure 15. Global Inflammatory Bowel Disease (IBD) Drugs Market Share by Players in 2022
Figure 16. Global Top Inflammatory Bowel Disease (IBD) Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inflammatory Bowel Disease (IBD) Drugs as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Inflammatory Bowel Disease (IBD) Drugs Revenue in 2022
Figure 18. North America Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Inflammatory Bowel Disease (IBD) Drugs Market Share by Country (2018-2029)
Figure 20. United States Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Inflammatory Bowel Disease (IBD) Drugs Market Share by Country (2018-2029)
Figure 24. Germany Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Inflammatory Bowel Disease (IBD) Drugs Market Share by Region (2018-2029)
Figure 32. China Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Inflammatory Bowel Disease (IBD) Drugs Market Share by Country (2018-2029)
Figure 40. Mexico Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Inflammatory Bowel Disease (IBD) Drugs Market Share by Country (2018-2029)
Figure 44. Turkey Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Abbott Laboratories Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
Figure 47. Biocon Ltd Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
Figure 48. Johnson and Johnson Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
Figure 49. Novartis AG Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
Figure 50. Pfizer Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
Figure 51. Quest Medical Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
Figure 52. Sanofi Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
Figure 53. Takeda Pharmaceutical Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
Figure 54. UCB Pharma Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
Figure 55. AbbVie Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
Figure 56. Zhejiang Hisun Pharmaceutical Co.,Ltd. Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
Figure 57. North China Pharmaceutical Co., Ltd. Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
Figure 58. Zhejiang Zhebei Pharmaceutical Co., Ltd. Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
Figure 59. Huadong Medicine Co., Ltd. Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
Figure 60. Shenzhen Salubris Pharmaceuticals Co.,Ltd. Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
Figure 61. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Figure 1. Global Inflammatory Bowel Disease (IBD) Drugs Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Inflammatory Bowel Disease (IBD) Drugs Market Share by Type: 2022 VS 2029
Figure 3. Aminosalicylate Features
Figure 4. Corticosteroid Hormone Features
Figure 5. Immunosuppressants Features
Figure 6. Biological Agents Features
Figure 7. Global Inflammatory Bowel Disease (IBD) Drugs Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Inflammatory Bowel Disease (IBD) Drugs Market Share by Application: 2022 VS 2029
Figure 9. Ulceratory Colitis Case Studies
Figure 10. Crohn's Disease Case Studies
Figure 11. Inflammatory Bowel Disease (IBD) Drugs Report Years Considered
Figure 12. Global Inflammatory Bowel Disease (IBD) Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Inflammatory Bowel Disease (IBD) Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Inflammatory Bowel Disease (IBD) Drugs Market Share by Region: 2022 VS 2029
Figure 15. Global Inflammatory Bowel Disease (IBD) Drugs Market Share by Players in 2022
Figure 16. Global Top Inflammatory Bowel Disease (IBD) Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inflammatory Bowel Disease (IBD) Drugs as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Inflammatory Bowel Disease (IBD) Drugs Revenue in 2022
Figure 18. North America Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Inflammatory Bowel Disease (IBD) Drugs Market Share by Country (2018-2029)
Figure 20. United States Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Inflammatory Bowel Disease (IBD) Drugs Market Share by Country (2018-2029)
Figure 24. Germany Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Inflammatory Bowel Disease (IBD) Drugs Market Share by Region (2018-2029)
Figure 32. China Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Inflammatory Bowel Disease (IBD) Drugs Market Share by Country (2018-2029)
Figure 40. Mexico Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Inflammatory Bowel Disease (IBD) Drugs Market Share by Country (2018-2029)
Figure 44. Turkey Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Inflammatory Bowel Disease (IBD) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Abbott Laboratories Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
Figure 47. Biocon Ltd Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
Figure 48. Johnson and Johnson Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
Figure 49. Novartis AG Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
Figure 50. Pfizer Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
Figure 51. Quest Medical Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
Figure 52. Sanofi Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
Figure 53. Takeda Pharmaceutical Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
Figure 54. UCB Pharma Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
Figure 55. AbbVie Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
Figure 56. Zhejiang Hisun Pharmaceutical Co.,Ltd. Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
Figure 57. North China Pharmaceutical Co., Ltd. Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
Figure 58. Zhejiang Zhebei Pharmaceutical Co., Ltd. Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
Figure 59. Huadong Medicine Co., Ltd. Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
Figure 60. Shenzhen Salubris Pharmaceuticals Co.,Ltd. Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
Figure 61. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Drugs Business (2018-2023)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
